T 0246/16 (Pharmaceutical compositions comprising botulinum neurotoxin for use in medicine and cosmetics/Ipsen Biopharm Limited) of 26.10.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:T024616.20171026
- Date of decision
- 26 October 2017
- Case number
- T 0246/16
- Online on
- 26 February 2018
- Petition for review of
- -
- Application number
- 10010686.3
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Pharmaceutical compositions comprising botulinum neurotoxin for use in medicine and cosmetics
- Applicant name
- Ipsen Biopharm Limited
- Opponent name
- ALLERGAN, INC.
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- Rules of procedure of the Boards of Appeal Art 12(2)Rules of procedure of the Boards of Appeal Art 13(3)European Patent Convention Art 100(b)European Patent Convention Art 100(c)European Patent Convention Art 56
- Keywords
- Admission of new evidence - No
Admission of auxiliary request - Yes
Amendments - Yes
Inventive step - Yes - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent on the basis of the set of claims of auxiliary request 1A filed with letter of 29 August 2016 (which is now the main request) and a description to be adapted.